Cargando…

Diagnostic Roles of Immunohistochemical Markers CK20, CD44, AMACR, and p53 in Urothelial Carcinoma In Situ

Background and Objectives: This study aimed to evaluate the diagnostic roles of various immunohistochemical (IHC) markers in urothelial carcinoma in situ (uCIS) through a meta-analysis and review of diagnostic test accuracy. Materials and Methods: The IHC markers CK20, CD44, AMACR, and p53 were eval...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoo, Daeseon, Min, Kyueng-Whan, Pyo, Jung-Soo, Kim, Nae Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533139/ https://www.ncbi.nlm.nih.gov/pubmed/37763728 http://dx.doi.org/10.3390/medicina59091609

Ejemplares similares

CK20 versus AMACR and p53 immunostains in evaluation of Urothelial Carcinoma in Situ and Reactive Atypia
por: Neal, Daniel J., et al.
Publicado: (2020)

Does the addition of AMACR to CK20 help to diagnose challenging cases of urothelial carcinoma in situ?
por: Alston, Erin L. J., et al.
Publicado: (2019)

Diagnostic and Prognostic Roles of GATA3 Immunohistochemistry in Urothelial Carcinoma
por: Yoo, Daeseon, et al.
Publicado: (2023)

Diagnostic utility of p53 and CK20 immunohistochemical expression grading urothelial malignancies
por: Mumtaz, Shazia, et al.
Publicado: (2014)

Differential diagnosis of urothelial carcinoma in situ from non-neoplastic urothelia: Analysis of CK20, CD44, P53 and Ki67
por: Asgari, Mojgan, et al.
Publicado: (2016)

CK20 and CK5/6 Immunohistochemical Staining of Urothelial Neoplasms: A Perspective
por: Akhtar, Mohammed, et al.
Publicado: (2020)

Evaluation of P53 and CK20 Immunohistochemical Markers in Comparison with Morphologic Findings in Low- and High-grade Urothelial Carcinomas
por: Ahadi, Mahsa, et al.
Publicado: (2021)

Differential immunohistochemical expression of DEC1, CK-1ε, and CD44 in oral atypical squamous epithelium and carcinoma in situ
por: Sato, Fuyuki, et al.
Publicado: (2022)

An Immunohistochemical Expression of CK5/6, CK7, and CK20 on Cell Blocks in Metastatic Cervical Lymphadenopathy
por: Kaur, Amanpreet, et al.
Publicado: (2022)

Diagnostic Value of Cytokeratin 34 beta E12 (Ck34βE12) and α-Methylacyl-CoA racemase (AMACR) Immunohistochemical Expression in Prostatic Lesions
por: Hasan, Ikram A., et al.
Publicado: (2020)

Comparative analysis of three- and two-antibody cocktails to AMACR and basal cell markers for the immunohistochemical diagnosis of prostate carcinoma
por: Dabir, Parag Deepak, et al.
Publicado: (2012)

Prognostic impact of immunohistochemical expression of CK7 and CK20 in curatively resected ampulla of Vater cancer
por: Yun, Sung Pil, et al.
Publicado: (2015)

Evaluation of a triple combination of cytokeratin 20, p53 and CD44 for improving detection of urothelial carcinoma in urine cytology specimens
por: Arville, Brent, et al.
Publicado: (2013)

The Intraoperative Immunohistochemical Staining of CD56 and CK19 Improves Surgical Decision for Thyroid Follicular Lesions
por: Pyo, Ju Yeon, et al.
Publicado: (2017)

Utility of AMACR immunohistochemical staining in differentiating Arias-Stella reaction from clear cell carcinoma of ovary and endometrium
por: Nili, Fatemeh, et al.
Publicado: (2023)

Immunohistochemical Expression of Alpha-Methyl-Coa (AMACR) and ERG in Prostatic Adenocarcinoma and Prostatic Hyperplasia: A Comparative Study
por: Samir Sayed, Rasha Mohamed, et al.
Publicado: (2023)

The expressions of AMACR and iNOS in prostate adenocarcinomas
por: Ozgur, Tumay, et al.
Publicado: (2013)

Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosis
por: Sikic, Danijel, et al.
Publicado: (2017)

Significance of Tumor–Stroma Ratio (TSR) in Predicting Outcomes of Malignant Tumors
por: Pyo, Jung-Soo, et al.
Publicado: (2023)

Expression of the Immunohistochemical Markers CK5, CD117, and EGFR in Molecular Subtypes of Breast Cancer Correlated with Prognosis
por: Schulmeyer, Carla E., et al.
Publicado: (2023)

Global expression of AMACR transcripts predicts risk for prostate cancer – a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate
por: Alinezhad, Saeid, et al.
Publicado: (2016)

Use of immunohistochemical analysis of CK5/6, CK14, and CK34betaE12 in the differential diagnosis of solid papillary carcinoma in situ from intraductal papilloma with usual ductal hyperplasia of the breast
por: Maeda, Ichiro, et al.
Publicado: (2018)

Evaluation of Immunohistochemical Markers, CK17 and SOX2, as Adjuncts to p53 for the Diagnosis of Differentiated Vulvar Intraepithelial Neoplasia (dVIN)
por: Dasgupta, Shatavisha, et al.
Publicado: (2021)

Immunohistochemical expression of p53, Ki67, α-SMA, CD44 and CD31 in different histological subtypes of basal cell carcinoma
por: Cojocaru, Anca, et al.
Publicado: (2022)

Immunohistochemical analysis of CD44s and CD44v6 in endometriosis and adenomyosis : comparison with normal, hyperplastic, and malignant endometrium.
por: Lin, Z., et al.
Publicado: (2001)

Expression of the Cancer Stem Cell Markers CD44 and CD133 in Colorectal Cancer: An Immunohistochemical Staining Analysis
por: Hong, Injae, et al.
Publicado: (2015)

Selection of aptamers for AMACR detection from DNA libraries with different primers
por: Yang, Deng-Kai, et al.
Publicado: (2018)

PanCD44 Immunohistochemical Evaluation in Prostatectomies from Patients with Adenocarcinoma
por: Hirth, Carlos Gustavo, et al.
Publicado: (2018)

Immunohistochemical Detection of Cancer Stem Cell Related Markers CD44 and CD133 in Metastatic Colorectal Cancer Patients
por: Pitule, Pavel, et al.
Publicado: (2014)

Clinicopathological Significances of Positive Surgical Resection Margin after Radical Prostatectomy for Prostatic Cancers: A Meta-Analysis
por: Kim, Minseok, et al.
Publicado: (2022)

CK 20‐positive and CK 7‐negative Merkel cell carcinoma of the cheek
por: Rai, Manoj Ponadka, et al.
Publicado: (2018)

A study on the AMACR catalysed elimination reaction and its application to inhibitor testing
por: Yevglevskis, Maksims, et al.
Publicado: (2016)

Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer.
por: Sliutz, G., et al.
Publicado: (1995)

CD44 Expression in Oral Lichen Planus and Related Lesions—An Immunohistochemical Study
por: Chandrasekar, Muthulakshmi, et al.
Publicado: (2023)

AMACR overexpression acts as a negative prognostic factor in oral squamous cell carcinoma
por: He, Hong-Lin, et al.
Publicado: (2018)

Alpha-Methylacyl-CoA Racemase (AMACR), a Potential New Biomarker for Glioblastoma
por: Lee, Hyunji, et al.
Publicado: (2020)

Diagnostic utility of triple antibody (AMACR, HMWCK and P63) stain in prostate neoplasm
por: Rathod, Santosh G., et al.
Publicado: (2019)

Urine Exosomal AMACR Is a Novel Biomarker for Prostate Cancer Detection at Initial Biopsy
por: Jin, Xin, et al.
Publicado: (2022)

Diagnostic Accuracy of ki-67 Labeling Index in Endoscopic Ultrasonography-Fine-Needle Aspiration Cytology and Biopsy of Pancreatic Neuroendocrine Neoplasms
por: Pyo, Jung-Soo, et al.
Publicado: (2023)

Immunohistochemical evaluation of CD20 expression in patients with multiple myeloma
por: Yavasoglu, Irfan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nuk93m1e35olukt8bd99bhusna